In an effort to make its obesity treatment drug, Zepound, more accessible, Eli Lilly introduced 2.5mg and 5mg single-dose vials through its self-pay channels, Lilly Direct. Additionally ...

The company has made its obesity treatment drug, Zepound, more accessible by introducing 2.5mg and 5mg single-dose vials through its self-pay channels, Lilly Direct. Lastly, the Biden administration ...

Eli Lilly also completed the acquisition of Morphic Holding (NASDAQ:MORF), Inc., adding a therapy for inflammatory bowel disease to its portfolio. In an effort to make its obesity treatment drug, ...

On the ratings front, BMO Capital and Morgan Stanley have maintained their Outperform and Overweight ratings for Eli Lilly, respectively, while Evercore ISI has maintained an In Line rating. The ...

BMO Capital and Morgan Stanley have maintained their Outperform and Overweight ratings for Eli Lilly, respectively, while Evercore ISI has maintained an In Line rating. The company has made its ...

TD Cowen has maintained a Buy rating on Eli Lilly's shares, reflecting confidence in the company's continued growth and its ability to capitalize on its pipeline developments. The company has made its ...